Don't have an account?
doses currently produced globally every year1
more iodinated contrast media doses to be delivered annually by 20251
accredited contrast media production facilities globally
invested over the last decade to increase capacity2
GE HealthCare has a distinguished heritage of contrast media development, offering a comprehensive product range across modalities, with a range of concentrations and innovative packaging choices.
Beyond the scan
Beyond the scan
Active Pharmaceutical Ingredients investment
$80 million invested to expand production at our Lindesnes, Norway API facility.
Contrast media production investment
Opening of new €30m manufacturing line in Cork to increase contrast media supply.
Focusing on precision medicine from injection to diagnosis. Each dose, each patient, improving every day. Explore our broad portfolio of contrast media products and solutions.
Our +PLUS PAK packaging, used for contrast media product, is 100% recyclable. A life-cycle analysis showed that our polypropylene bottles, compared to glass, have a 59% lower environmental impact, and requires 45% less cumulative energy. Our +PLUS PAK bottles, also require less secondary packaging, helping reduce carbon footprint.3
1. GE HealthCare Data on File: Planned Investment 2022
2. GE HealthCare Data on File: Contrast Media Demand; 2022
3. Dhaliwal et al. Int J Life Cycle Assess 2014; 19: 1965-73.
4. GE HealthCare Data on File: iodine-recycling program 2022
cGMP: Current Good Manufacturing Practice
JB00294BS/IN/05/2023